• 首页期刊简介编委会刊物订阅专栏专刊电子刊学术动态联系我们English
引用本文:田晓,魏建芬,刘晓慧,冯晓明.百令胶囊对糖尿病肾病腹膜透析患者VEGF活性、炎症因子的影响[J].中国现代应用药学,2014,31(7):891-894.
TIAN Xiao,WEI Jianfen,LIU Xiaohui,FENG Xiaoming.Influecnce of Bailing Capsule on the Activity of VEGF and Inflammatory Factor of The Diabetic Nephropathy Patients with Peritoneal Dialysis[J].Chin J Mod Appl Pharm(中国现代应用药学),2014,31(7):891-894.
【打印本页】   【HTML】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 2574次   下载 2025 本文二维码信息
码上扫一扫!
分享到: 微信 更多
百令胶囊对糖尿病肾病腹膜透析患者VEGF活性、炎症因子的影响
田晓1, 魏建芬1, 刘晓慧2, 冯晓明1
1.河北联合大学附属医院,唐山 063000;2.河北省正定县人民医院,河北 正定 050800
摘要:
目的 通过临床随机对照试验探讨腹膜透析患者应用百令胶囊后对血管内皮细胞生长因子(vascular endothelial growth factor,VEGF)、炎症因子活性的影响。方法 行持续不卧床腹膜透析一个月以上的糖尿病肾病患者52例,按随机表法分成百令组和对照组,采用ELASE法分别测试用药前及用药1个月后患者血清及透出液VEGF活性、血清炎症因子的变化。结果 百令组用药后血清及透出液VEGF活性均较用药前降低,差异有统计学意义( P <0.01);百令组用药后炎症因子较用药前降低,差异有统计学意义( P <0.05);百令组用药后血清及透出液VEGF活性较对照组降低,差异有统计学意义( P <0.01)。结论 百令胶囊能降低腹膜透析患者血清及透出液中VEGF活性及炎症因子浓度,并可改善微炎症状态。
关键词:  百令胶囊  腹膜透析  细胞内皮生长因子  炎症因子
DOI:
分类号:
基金项目:
Influecnce of Bailing Capsule on the Activity of VEGF and Inflammatory Factor of The Diabetic Nephropathy Patients with Peritoneal Dialysis
TIAN Xiao1, WEI Jianfen1, LIU Xiaohui2, FENG Xiaoming1
1.Hebei Union University Affiliated Hospital, Tangshan 063000, China;2.People’s Hospital of Zhengding Country, Zhengding 050800, China
Abstract:
OBJECTIVE To explore the influence of the activity of vascular endothelial cell growth factor(VEGF), and the activity of inflammatory factor through clinical randomized controlled trials on patients with peritoneal dialysis by administration of Bailing capsule. METHODS According to randomized table, 52 diabetic nephrology patients who accept continuous ambulatory peritoneal dialysis for one month or more in our hospital were divided into Bailing capsule group and control group. The variation of the activity of the VEGF, inflammatory factor in serum and in dialysate was tested by ELISA before and after administration of the drug for one month. RESULTS In Bailing capsule group, the activity of the VEGF in serum and in dialysate after administration of the drug was significantly decreased compared with that before administration( P <0.01). In Bailing capsule group, the inflammatory factor was significantly decreased( P <0.05). The activity of VEGF in serum and in dialysate of Bailing capsule group significantly decreased compared with that in the control group( P <0.01).CONCLUSION Bailing capsule can reduce VEGF activity and inflammatory factors content in serum and in dialysate of peritonel dialysis patients, and can improve slightly inflammatory state.
Key words:  Bailing capsule  peritoneal dialysis  vascular endothelial growth factor  inflammatory fators
扫一扫关注本刊微信